Print Page   |   Contact Us   |   Sign In
Community Search
 ADVERTISEMENTS 
This section will be used for adverts.
Pharmaceutical Companies can advertise here.
Adverts will be rated and run on monthly basis.
it will be first come first served basis


BNF:
Available at the PSGH secretariat
  • British National Formulary 
    Book by Royal Pharmaceutical Society of Great Britain and British Medical Association
  • The British National Formulary is a pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about medicines.
  • PSGH CLOTH and other materials
  • Available at the PSGH Secretariat

  • EXCEMED – Excellence in Medical Education - 2014 Tour in Africa - For Pharmacists - ACCRA
    View Registrations Tell a Friend About This EventTell a Friend
     

    06/11/2014
    When: 2014/11/06
    1:30 PM
    Where: College of Health Sciences, Faculty of Pharmacy and Pharmaceutical Science - KNUST
    Accra
    Ghana
    « Go to Upcoming Event List  

    THE PHARMACEUTICAL SOCIETY OF GHANA (PSGH) IN COLLABORATION WITH EXCEMED-EXCELLENCE IN MEDICAL EDUCATION; THE FACULTY OF PHARMACY AND PHARMACEUTICAL SCIENCES (FFPS), KNUST AND THE SCHOOL OF PHARMACY, UNIVERSITY OF GHANA, LEGON

     PRESENTS

     An International Course on Clinical Chronic Diseases Management - Diabetes and Hypertension

     Aim

    Diabetes and hypertension are growing epidemics in the most of the African continent that are rapidly adopting western lifestyles. The EXCEMED – Excellence in Medical Education, has an ongoing, long-term educational project to provide additional focused training workshops for pharmacy students in the final year of their education and pharmacists. EXCEMED hopes that by prioritising diabetes and hypertension it will be possible to increase the understanding and the awareness of the opportunities for preventing these conditions. Hypertension and its sequelae will be explored in detail, including its diagnosis, the potential and-organ damage such as CHD, stroke and peripheral vascular disease, and the possible treatment modalities and their effects.

    Diabetes will also be a major focus and teaching will include aetiology, complications (both macrovascular and microvascular) and treatment options. Acute metabolic presentations of diabetes and their inpatient treatment will also be covered. Attendees will learn more about the interaction between diabetes, dyslipidemia and hypertension and the importance of multiple interventions in their management. The current state of detection and prevention of these conditions in the local economy will be examined and students will explore models of the future development of services, together with the potential impact on their own medical careers. The CME tour will provide a mixture of taught and interactive sessions. The taught lectures will be presented by a speaker supported by slides, but will include ample opportunity for students to ask questions. The interactive sessions will centre on discussions of individual cases, and each will be presented by a learner with a faculty member who will discuss the case interactively with the attendees by eliciting the ideas on differential diagnosis, investigations and management strategies. Sessions will be taught not only by the visiting faculty but also by teaching staff from the host universities. Learners  will have the opportunity during the live educational course to reflect on the factual knowledge that has been provided and will be able to deepen and extend their knowledge through direct contact with the faculty.

     

    Learning objectives

    After attending the CME tour, attendees will be able to:

    ·  Describe the developing epidemic of obesity, hypertension and diabetes and their sequelae.

    ·  Interpret the nature, aetiology, diagnosis and cardiovascular complications and treatment of (i) hypertension and (ii) diabetes.

    ·  Identify the specific chronic complications of diabetes that will contribute to its major health burden.

    ·  Differentiate acute metabolic presentations of diabetes and their inpatient treatment

    ·  Identify the current state of detection and prevention of hypertension and diabetes in the local economy and models of future development of services, together with the potential impact on their medical careers

     

    Target audience

    This live educational course is appropriate for undergraduate students, endocrinologists, diabetologists, cardiologists, pharmacists and other healthcare professionals involved in the management of patients with diabetes or hypertension.

     

    Venue

     6 November 2014 - University of Ghana, Wetlands Auditorium, near School of Pharmacy - Accra , Ghana

     

    Scientific organiser

    Prof. Jonathan Levy

    Oxford Centre for Diabetes, Endocrinology and Metabolism

    Churchill Hospital

    Oxford, United Kingdom

     

    Faculty members

    Prof. Vittorio Colizzi- European Speaker

    Dr. Barima Afrane - School of Pharmacy, University of Ghana

    Pharm. Philip Anum- Ghana College of Pharmacists

    Dr. Kwame Ohene Buabeng- Faculty of Pharmacy and Pharmaceutical Sciences, KNUST

    Dr. Berko Panyin Anto   -  Faculty of Pharmacy and Pharmaceutical Sciences, KNUST

     

    Scientific Secretariat

    EXCEMED - Excellence in Medical Education

    Salita di San Nicola da Tolentino, 1/b

    00187 Rome, Italy

    Associate Programme Manager: Simona Gaudiosi

    Specialist Medical Advisor: Prof. Jonathan Levy

    Tel.: +39 06 420413 308

    Fax: +39 06 420413 677

    E-mail: info@excemed.org

    EXCEMED is a Swiss Foundation with headquarters in

    14, Rue du Rhône, 1204 Geneva, Switzerland

     

    PARTICIPATION FEE: FREE

     

    SCIENTIFIC AGENDA  - PHARMACIST PRATICTIONERS 

    Thursday afternoon, 6 November, 2014 - Wetlands Auditorium, near School of Pharmacy, University of Ghana, Legon.

                                                                                                                                                                                   

    14.00     Welcome and introduction to the course

                    Local speaker                                                                                                    

    14.05     Initial questionnaire                                                                       

    14.20     L1   Why lower blood glucose: symptoms & complication prevention      

                    European visiting speaker

    14.25     L2   Simple physiology of diabetes: type 1, type 2; beta cell deficit; progression of diabetes   

                      European visiting speaker

    14.40     L3   Specific targets: beta cells & insulin requirement:                                                                                 Type 1 DM & insulin                                                                                                                  

                        Type 2 DM & oral medications enumerate targets & attach drugs & mechanism of action           

                    European visiting speaker

    15.30     L4   Adverse effects       

                    European visiting speaker

    15.40     L5   Combining drugs

                    European visiting speaker                

    15.45     Questions from the pharmacists

     

    16.00     Coffee break       

                                                                                                                                    

    16.20     L6   Practicalities: availability, cost, population reach       

                       Local speaker                                                                                    

    16.35     L7   Blood glucose targets and efficacy

                    European visiting speaker

    16.40     L8   Clinical outcome targets: complications                         

                    European visiting speaker

    16.55     L9   Patient centred clinical practice and compromise

                      European visiting speaker

    17.00     Clinical case presentations and discussions

                      Local speaker                                                                                    

    17.10     L10  Other risk factors (hypertension & lipids) and interventions

                        European visiting speaker  

    17.20       Final questionnaire                                                                                                                                   

    17.35        Closing remarks                                                                                                                                

    17.40        End of the course